BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29034688)

  • 21. Models of care for motor neuron disease: setting standards.
    Hardiman O; Traynor BJ; Corr B; Frost E
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Dec; 3(4):182-5. PubMed ID: 12710506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive management of amyotrophic lateral sclerosis.
    Carter GT; Miller RG
    Phys Med Rehabil Clin N Am; 1998 Feb; 9(1):271-84, viii-ix. PubMed ID: 9894144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spirituality and/or religious faith: A means for coping with the effects of amyotrophic lateral sclerosis/motor neuron disease?
    O'Brien MR; Clark D
    Palliat Support Care; 2015 Dec; 13(6):1603-14. PubMed ID: 25851240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of dyspnea in advanced motor neuron diseases.
    Tripodoro VA; De Vito EL
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):173-9. PubMed ID: 18685417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Access to palliative care for people with motor neurone disease in New Zealand.
    McKenna C; MacLeod R
    N Z Med J; 2005 Sep; 118(1222):U1667. PubMed ID: 16222359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture.
    Fong KY; Yu YL; Chan YW; Kay R; Chan J; Yang Z; Kwan MC; Leung KP; Li PC; Lam TH; Cheung RT
    Neuroepidemiology; 1996; 15(5):239-45. PubMed ID: 8878076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical issues in palliative care--an overview.
    Oliver D
    Palliat Med; 1993; 7(4 Suppl):15-20. PubMed ID: 7505706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The meaning of living with uncertainty for people with motor neurone disease.
    Harris DA; Jack K; Wibberley C
    J Clin Nurs; 2018 May; 27(9-10):2062-2071. PubMed ID: 29518277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and factors associated with advanced care directives in a motor neuron disease multidisciplinary clinic in Australia.
    Phua CS; Ng A; Brooks C; Harrington Z; Vedam H; Huynh T; Seccombe D; Aouad P; Cordato D
    Postgrad Med J; 2021 Sep; 97(1151):566-570. PubMed ID: 32788311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent Specialized Palliative Care Upon Initiation of First-Line Chemotherapy for Cancer Progression: Is It Early Enough?
    Nakajima N; Abe Y
    Am J Hosp Palliat Care; 2016 May; 33(4):340-5. PubMed ID: 25433067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experiences of dying, death and bereavement in motor neurone disease: a qualitative study.
    Whitehead B; O'Brien MR; Jack BA; Mitchell D
    Palliat Med; 2012 Jun; 26(4):368-78. PubMed ID: 21712334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidisciplinary management of motor neurone disease.
    Lau FS; Brennan FP; Gardiner MD
    Aust J Gen Pract; 2018 Sep; 47(9):593-597. PubMed ID: 30244551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management guidelines for motor neurone disease patients on non-invasive ventilation at home.
    Eng D
    Palliat Med; 2006 Mar; 20(2):69-79. PubMed ID: 16613402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dying at home: a way of maintaining control for the person with ALS/MND.
    Moore MK
    Palliat Med; 1993; 7(4 Suppl):65-8. PubMed ID: 7505712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis.
    Oliver DJ; Campbell C; O'brien T; Sloan R; Sykes N; Tallon C; Taylor-Horan J; Udoma M
    Amyotroph Lateral Scler; 2010 Dec; 11(6):562-4. PubMed ID: 20565331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptom relief during last week of life in neurological diseases.
    Ozanne A; Sawatzky R; Håkanson C; Alvariza A; Fürst CJ; Årestedt K; Öhlén J
    Brain Behav; 2019 Aug; 9(8):e01348. PubMed ID: 31287226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health professionals' responses to multiple sclerosis and motor neurone disease.
    Carter H; McKenna C; MacLeod R; Green R
    Palliat Med; 1998 Sep; 12(5):383-94. PubMed ID: 9924601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive ventilation in motor neuron disease: an update of current UK practice.
    O'Neill CL; Williams TL; Peel ET; McDermott CJ; Shaw PJ; Gibson GJ; Bourke SC
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):371-6. PubMed ID: 21849339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of integrated palliative care on the quality of end-of-life care: retrospective analysis of 521 cancer patients.
    Colombet I; Montheil V; Durand JP; Gillaizeau F; Niarra R; Jaeger C; Alexandre J; Goldwasser F; Vinant P
    BMJ Support Palliat Care; 2012 Sep; 2(3):239-47. PubMed ID: 24654196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of patients with advanced motor neuron disease.
    Wu PY
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Mar; 61(3):141-5. PubMed ID: 9556945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.